240 related articles for article (PubMed ID: 28887761)
21. Global heterogeneity assessed with
Tello Galán MJ; García Vicente AM; Pérez Beteta J; Amo Salas M; Jiménez Londoño GA; Pena Pardo FJ; Soriano Castrejón ÁM; Pérez García VM
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2019; 38(5):290-297. PubMed ID: 31427247
[TBL] [Abstract][Full Text] [Related]
22. Prognostic Value of Percentage Change in Metabolic Parameters as Measured by Dual-Time Point
Yoo J; Yoon HJ; Kim BS
J Womens Health (Larchmt); 2017 Oct; 26(10):1131-1137. PubMed ID: 28498790
[TBL] [Abstract][Full Text] [Related]
23. Metabolic changes in breast cancer on dual-time-point
Kim HO; Kim BS; Kang SY; Bang JI; An J; Kim JH; Yoon HJ
Ann Nucl Med; 2020 Dec; 34(12):942-951. PubMed ID: 32974848
[TBL] [Abstract][Full Text] [Related]
24. Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer.
Zhang H; Wroblewski K; Liao S; Kampalath R; Penney BC; Zhang Y; Pu Y
Acad Radiol; 2013 Jan; 20(1):32-40. PubMed ID: 22999369
[TBL] [Abstract][Full Text] [Related]
25. Predicting Response to Neoadjuvant Chemoradiotherapy in Esophageal Cancer with Textural Features Derived from Pretreatment
Beukinga RJ; Hulshoff JB; van Dijk LV; Muijs CT; Burgerhof JGM; Kats-Ugurlu G; Slart RHJA; Slump CH; Mul VEM; Plukker JTM
J Nucl Med; 2017 May; 58(5):723-729. PubMed ID: 27738011
[TBL] [Abstract][Full Text] [Related]
26. Heterogeneity index evaluated by slope of linear regression on
Kim YI; Kim YJ; Paeng JC; Cheon GJ; Lee DS; Chung JK; Kang KW
Eur J Nucl Med Mol Imaging; 2017 Nov; 44(12):1995-2003. PubMed ID: 28634684
[TBL] [Abstract][Full Text] [Related]
27. Textural features of
Saleem BR; Beukinga RJ; Boellaard R; Glaudemans AW; Reijnen MM; Zeebregts CJ; Slart RH
Eur J Nucl Med Mol Imaging; 2017 May; 44(5):886-894. PubMed ID: 28013350
[TBL] [Abstract][Full Text] [Related]
28. Texture analysis of high-resolution dedicated breast
Moscoso A; Ruibal Á; Domínguez-Prado I; Fernández-Ferreiro A; Herranz M; Albaina L; Argibay S; Silva-Rodríguez J; Pardo-Montero J; Aguiar P
Eur J Nucl Med Mol Imaging; 2018 Feb; 45(2):196-206. PubMed ID: 28936601
[TBL] [Abstract][Full Text] [Related]
29. Are pretreatment 18F-FDG PET tumor textural features in non-small cell lung cancer associated with response and survival after chemoradiotherapy?
Cook GJ; Yip C; Siddique M; Goh V; Chicklore S; Roy A; Marsden P; Ahmad S; Landau D
J Nucl Med; 2013 Jan; 54(1):19-26. PubMed ID: 23204495
[TBL] [Abstract][Full Text] [Related]
30. Comparison of prone versus supine 18F-FDG-PET of locally advanced breast cancer: Phantom and preliminary clinical studies.
Williams JM; Rani SD; Li X; Arlinghaus LR; Lee TC; MacDonald LR; Partridge SC; Kang H; Whisenant JG; Abramson RG; Linden HM; Kinahan PE; Yankeelov TE
Med Phys; 2015 Jul; 42(7):3801-13. PubMed ID: 26133582
[TBL] [Abstract][Full Text] [Related]
31. Ability of
Ou X; Wang J; Zhou R; Zhu S; Pang F; Zhou Y; Tian R; Ma X
Contrast Media Mol Imaging; 2019; 2019():4507694. PubMed ID: 30930700
[No Abstract] [Full Text] [Related]
32. Pretherapy 18F-fluorodeoxyglucose positron emission tomography/computed tomography robust radiomic features predict overall survival in non-small cell lung cancer.
Mostafa R; Abdelsamie Kandeel A; Abd Elkareem M; Nardo L; Abdelhafez YG
Nucl Med Commun; 2022 May; 43(5):540-548. PubMed ID: 35190518
[TBL] [Abstract][Full Text] [Related]
33. Prediction of Recurrence and Mortality of Locally Advanced Esophageal Cancer Patients Using Pretreatment F-18 FDG PET/CT Parameters: Intratumoral Heterogeneity, SUV, and Volumetric Parameters.
Chang S; Kim SJ
Cancer Biother Radiopharm; 2016 Feb; 31(1):1-6. PubMed ID: 26844846
[TBL] [Abstract][Full Text] [Related]
34. Impact of Image Reconstruction Settings on Texture Features in 18F-FDG PET.
Yan J; Chu-Shern JL; Loi HY; Khor LK; Sinha AK; Quek ST; Tham IW; Townsend D
J Nucl Med; 2015 Nov; 56(11):1667-73. PubMed ID: 26229145
[TBL] [Abstract][Full Text] [Related]
35. 18F-FDG semi-quantitative parameters and biological prognostic factors in locally advanced breast cancer.
García Vicente AM; Soriano Castrejón A; Relea Calatayud F; Muñoz Madero V; Molina Garrido MJ; León Martín AA; Cordero García JM; Pilkington Woll JP; Chacón López-Muñiz I; Palomar Muñoz A
Rev Esp Med Nucl Imagen Mol; 2012; 31(6):308-14. PubMed ID: 23084013
[TBL] [Abstract][Full Text] [Related]
36. The relationship between CEA and CA 15-3 positivity and metabolic and volumetric 18F-FDG PET/CT parameters in preoperative evaluation of breast cancer.
Can C; Arac E; Cakabay B; Guzel Y
Ann Ital Chir; 2022; 92():33-39. PubMed ID: 35342101
[TBL] [Abstract][Full Text] [Related]
37. FDG PET/CT texture analysis for predicting the outcome of lung cancer treated by stereotactic body radiation therapy.
Lovinfosse P; Janvary ZL; Coucke P; Jodogne S; Bernard C; Hatt M; Visvikis D; Jansen N; Duysinx B; Hustinx R
Eur J Nucl Med Mol Imaging; 2016 Jul; 43(8):1453-60. PubMed ID: 26830299
[TBL] [Abstract][Full Text] [Related]
38. Comparison of the volumetric and radiomics findings of 18F-FDG PET/CT images with immunohistochemical prognostic factors in local/locally advanced breast cancer.
Acar E; Turgut B; Yiğit S; Kaya G
Nucl Med Commun; 2019 Jul; 40(7):764-772. PubMed ID: 30925542
[TBL] [Abstract][Full Text] [Related]
39. Inter-observer and segmentation method variability of textural analysis in pre-therapeutic FDG PET/CT in head and neck cancer.
Guezennec C; Bourhis D; Orlhac F; Robin P; Corre JB; Delcroix O; Gobel Y; Schick U; Salaün PY; Abgral R
PLoS One; 2019; 14(3):e0214299. PubMed ID: 30921388
[TBL] [Abstract][Full Text] [Related]
40. Reproducibility of F18-FDG PET radiomic features for different cervical tumor segmentation methods, gray-level discretization, and reconstruction algorithms.
Altazi BA; Zhang GG; Fernandez DC; Montejo ME; Hunt D; Werner J; Biagioli MC; Moros EG
J Appl Clin Med Phys; 2017 Nov; 18(6):32-48. PubMed ID: 28891217
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
